Now showing items 1-6 of 6

    • Addition of 7 days of zidovudine plus lamivudine to peripartum single-dose nevirapine effectively reduces nevirapine resistance postpartum in HIV-infected mothers in Malawi. 

      Farr, SL; Nelson, JA; Ng'ombe, TJ; Kourtis, AP; Chasela, C; Johnson, JA; Kashuba, AD; Tegha, GL; Wiener, J; Eron, JJ; Banda, HN; Mpaso, M; Lipscomb, J; Matiki, C; Fiscus, SA; Jamieson, DJ; van der Horst, C; BAN Study Team.; Meme, J (University of Nairobi, 2010-08)
      BACKGROUND: We assessed whether 7 days of zidovudine + lamivudine postpartum with single-dose nevirapine at labor decreases nevirapine resistance in HIV-infected women in Malawi. METHODS: HIV-infected pregnant women ...
    • The health of HIV-exposed children after early weaning. 

      Parker, ME; Tembo, M; Adair, L; Chasela, C; Piwoz, EG; Jamieson, DJ; Ellington, S; Kayira, D; Soko, A; Mkhomawanthu, C; Martinson, F; van der Horst, CM; Bentley ME, ME; BAN Study Team.; Meme, J (University of Nairobi, 2013-04)
      There are potential health risks associated with the use of early weaning to prevent mother-to-child transmission of human immunodeficiency virus (HIV) in resource-poor settings. Our objective was to examine growth and ...
    • Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants. 

      Chasela, CS; Kourtis, AP; Wall, P; Drobeniuc, J; King, CC; Thai, H; Teshale, EH; Hosseinipour, M; Ellington, S; Codd, MB; Jamieson, DJ; Knight, R; Fitzpatrick, P; Kamili, S; Hoffman, I; Kayira, D; Mumba, N; Kamwendo, DD; Martinson, F; Powderly, W; Teo, CG; van der Horst, C; BAN Study Team.; Meme, J (University of Nairobi, 2014-03)
      BACKGROUND & AIMS: The extent of HBV infection to infants of HBV/HIV-coinfected pregnant women in sub-Saharan Africa is unknown. The aim of this study was to assess prevalence of HBV infection among antiretroviral-naïve, ...
    • Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial. 

      Jamieson, DJ; Chasela, CS; Hudgens, MG; King, CC; Kourtis, AP; Kayira, D; Hosseinipour, MC; Kamwendo, DD; Ellington, SR; Wiener, JB; Fiscus, SA; Tegha, G; Mofolo, IA; Sichali, DS; Adair, LS; Knight, RJ; Martinson, F; Kacheche, Z; Soko, A; Hoffman, I; van der Horst C, C; BAN study team.; Meme, J (University of Nairobi, 2012-06)
      BACKGROUND: In resource-limited settings where no safe alternative to breastfeeding exists, WHO recommends that antiretroviral prophylaxis be given to either HIV-infected mothers or infants throughout breastfeeding. We ...
    • Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. 

      Chasela, CS; Hudgens, MG; Jamieson, DJ; Kayira, D; Hosseinipour, MC; Kourtis, AP; Martinson, F; Tegha, G; Knight, RJ; Ahmed, Y; Kamwendo, DD; Hoffman, IF; Ellington, SR; Kacheche, Z; Soko, A; Wiener, JB; Fiscus, SA; Kazembe, P; Mofolo, IA; Chigwenembe, M; Sichali, DS; van der Horst, CM; BAN Study Group.; Meme, J (University of Nairobi, 2010-06)
      BACKGROUND: We evaluated the efficacy of a maternal triple-drug antiretroviral regimen or infant nevirapine prophylaxis for 28 weeks during breast-feeding to reduce postnatal transmission of human immunodeficiency virus ...
    • Prevalence of hepatitis C virus infection among human immunodeficiency virus-1-infected pregnant women in Malawi: the BAN study. 

      Chasela, CS; Wall, P; Drobeniuc, J; King, CC; Teshale, E; Hosseinipour, MC; Ellington, SR; Codd, M; Jamieson, DJ; Knight, RJ; Fitzpatrick, P; Kourtis, AP; Hoffman, IF; Kayira, D; Mumba, N; Kamwendo, DD; Martinson, F; Powderly, W; van der Horst, C; BAN Study Team.; Meme, J (University of Nairobi, 2012-08)
      BACKGROUND: In Sub-Saharan Africa, prevalence estimates of hepatitis C virus (HCV) vary widely. OBJECTIVES: To assess the prevalence of HCV infection among HIV-infected, pregnant women screened for a large clinical ...